ロード中...
Nanocarrier vaccines for SARS-CoV-2
The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death associated with substantive social, economic and societal impacts. Treatments rely on re-purposed antivirals and immune modulatory agents focusing on attenuating the acute respiratory distress syndrome. No curative t...
保存先:
| 出版年: | Adv Drug Deliv Rev |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Published by Elsevier B.V.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7794055/ https://ncbi.nlm.nih.gov/pubmed/33428995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2021.01.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|